Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model

Life Sciences

Volumn 78, Issue 24, 2006, Pages 2839-2851

  Chakraborty, Tridib ^a   Chatterjee, Amrita ^a   Saralaya, M G ^a   Dhachinamoorthi, D ^a   Chatterjee, Malay ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Chromosomal aberrations; GGT; Hepatocarcinogenesis; PCNA; Vanadium

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; CYCLINE; DRINKING WATER; GAMMA GLUTAMYLTRANSFERASE; IRON; N (2 FLUORENYL)ACETAMIDE; SELENIUM; TRACE ELEMENT; VANADIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER MODEL; CHEMOPROPHYLAXIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEEDING; IN VIVO STUDY; INCIDENCE; LIVER CARCINOGENESIS; LIVER CELL; LIVER NODULE; LIVER WEIGHT; MALE; NONHUMAN; PHENOTYPE; PRECANCER; RAT; STATISTICAL SIGNIFICANCE;

2-ACETYLAMINOFLUORENE; ANIMALS; ANTICARCINOGENIC AGENTS; BODY WEIGHT; CARCINOGENS; CHROMOSOME ABERRATIONS; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; HEPATECTOMY; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METALS; ORGAN SIZE; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ATOMIC; VANADIUM;

MAMMALIA;

EID: 33646119860     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.11.015     Document Type: Article

References (50)

1. Ames B.N. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutation Research 475 1,2 (2001) 7-20
2. Bannasch P. Cytology and cytogenesis of neoplastic (hyperplastic) hepatic nodules. Cancer Research 36 7 PT 2 (1976) 2555-2562
3. 3 inhibit placental glutathione S-transferase positive foci in rat liver carcinogenesis. Life Sciences 68 2 (2000) 217-231
4. Bishayee A., and Chatterjee M. Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by Phenobarbital. British Journal of Cancer 71 6 (1995) 1214-1220
5. Bishayee A., Roy S., and Chatterjee M. Characterization of selective induction and alteration of xenobiotic biotransforming enzymes by vanadium during diethylnitrosamine-induced chemical rat liver carcinogenesis. Oncology Research 11 1 (1999) 41-53
6. Björkhem-Bergman L., Torndal U.B., Eken S., Nyström C., Capitanio A., Lassen E.H., Björnstedt M., and Eriksson L. Selenium prevents tumour development in a rat model for chemical carcinogenesis. Carcinogenesis 26 1 (2005) 125-131
7. Bohr V.A., and Dianov G.L. Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie 81 1-2 (1999) 155-160
8. Boiteux S., and Radicella J.P. Base excision repair of 8-hydroxyguanine protects DNA from endogenous oxidative stress. Biochimie 81 1-2 (1999) 59-67
9. Campbell H.A., Pitot H.C., Potter V.R., and Laishes B.A. Application of quantitative stereology to the evaluation of enzyme altered foci in rat liver. Cancer Research 42 2 (1982) 465-472
10. Chakraborty T., Ghosh S., Datta S., Chakraborty P., and Chatterjee M. Vanadium suppresses sister-chromatid exchange and DNA-protein crosslink formation and restores antioxidant status and hepatocellular architecture during 2-acetylaminofluorene-induced experimental rat hepatocarcinogenesis. Journal of Experimental Therapeutics and Oncology 3 6 (2003) 346-362
11. Cox D.H., and Bibb E.A. Hydrogen selenide evolution electrothermal atomic absorption method for determining nanogram levels of total selenium. Journal-Association of Official Analytical Chemists 64 2 (1981) 265-269
12. Daoust R., and Calamai R. Hyperbasophilic foci as sites of neoplastic transformation in hepatic parenchyma. Cancer Research 31 9 (1971) 1290-1296
13. Dave B.J., Hsu T.C., Hong W.K., and Pathak S. Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. International Journal of Oncology 5 (1994) 733-740
14. Eldridge S.E., Butterworth S.E., and Goldsworthy T.L. Proliferation cell nuclear antigen: a marker for hepatocellular proliferation in rodents. Environmental Health Perspectives 101 (1993) 211-218
15. Farber E. The multistep nature of cancer development. Cancer Research 44 12 Pt 1 (1984) 4217-4223
16. Farber E. Cellular biochemistry of the stepwise development of cancer with chemicals. Cancer Research 44 12 Pt 1 (1984) 5463-5474
17. Farber E. Clonal adaptation during carcinogenesis. Biochemical Pharmacology 39 (1990) 1837-1846
18. Farber E., and Cameron R. The sequential analysis of cancer development. Advances in Cancer Research 31 (1980) 125-226
19. Fenech M., and Ferguson L.R. Vitamins/minerals and genomic stability in humans. Mutation Research 475 1,2 (2001) 1-6
20. Feo F., Garcea R., Daino L., and Pascale R. Mechanism of the inhibition of liver hepatocarcinogenesis promotion by S-adenosyl-l-methionine. In: Roberfroid M.B., and Preat V. (Eds). Experimental Hepatocarcinogenesis (1988), Plenum, New York 197-207
21. Foiles P.G., Fujiki H., Suganuma M., Okabe S., Yatsunami J., Miglietta L.M., Upadhyaya P., El-Bayoumy K., and Ronai Z. Inhibition of PKC and PKA by chemopreventive organoselenium compounds. International Journal of Oncology 7 (1995) 685-690
22. French R.J., and Jones P.J. Role of vanadium in nutrition: metabolism, essentiality and dietary consideration. Life Sciences 52 4 (1993) 339-346
23. Gichner T., Cabrera Lopez G., Wagner E.D., and Plewa M.J. Induction of somatic mutations in tradescantia clone 4430 by three phenylenediamine isomers and the antimutagenic mechanisms of diethyldithiocarbamate and ammonium meta-vanadate. Mutation Research 306 2 (1994) 165-172
24. Grover S., and Fisher P. Cytogenetic studies in Sprague-Dawley rats during the administration of carcinogen nitroso compound-diethynitrosamine. European Journal of Cancer 7 1 (1971) 77-82
25. Gupta R.C., Earley K., and Becker F.F. Analysis of DNA adducts in putative premalignant hepatic nodules and nontarget tissues of rats during 2-acetylaminofluorene carcinogenesis. Cancer Research 48 18 (1988) 5270-5274
26. Hanigan M.H., and Pitot H.C. Gamma-glutamyl transpeptidase-its role in hepatocarcinogenesis. Carcinogenesis 6 2 (1985) 165-172
27. Holecek B.U., Kerler R.R., and Rabes H.M. Chromosomal analysis of a diethylnitrosamine-induced tumorigenic and a nontumorigenic rat liver cell line. Cancer Research 49 11 (1989) 3024-3028
28. Hopkins Jr. L.L., and Mohr H.E. The biological essentiality of vanadium. In: Mertz W., and Cornatzer W.E. (Eds). Newer Trace Elements in Nutrition (1971), Marcel Dekker, New York 195-213
29. Horiuchi T., Ito K., Suzuki M., and Umeda M. Sensitive induction of chromosome aberration in the in vivo liver cells of rats by N-nitrosodiethylamine. Mutation Research 140 4 (1984) 181-185
30. Kanna P.S., Mahendrakumar C.B., Indira B.N., Srivastawa S., Kalaiselvi K., Elayaraja T., and Chatterjee M. Chemopreventive effects of vanadium towards 1,2 dimethylhydrazine induced genotoxicity and preneoplastic lesions in rat colon. Environmental and Molecular Mutagenesis 44 2 (2004) 113-118
31. Kasprzak K.S., and Waalkes M.P. The role of calcium, magnesium, and zinc in carcinogenesis. Advances in Experimental Medicine and Biology 206 (1986) 497-515
32. Kato J., Kobune M., Kohgo Y., et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans cinnamon rats. The Journal of Clinical Investigation 98 4 (1996) 923-929
33. Keyer K., and Imlay J.A. Superoxide accelerates DNA damage by elevating free-iron levels. Proceedings of the National Academy of Sciences of the United States 93 24 (1996) 13635-13640
34. Kihlman B.A., Hansson K., and Andersson H.C. The effects of post-treatments with caffeine during S and G2 on the frequencies of chromosomal aberrations induced by thiotepa in root tips of Vicia faba and in human lymphocytes in vitro. Mutation Research 104 4-5 (1982) 323-330
35. Köpf-Maier P., and Kopf H. Transition and main-group metal cyclopentadienyl complexes: preclinical studies on a series of antitumor agents of different structural type. Structure and Bonding 70 (1988) 103-185
36. Land H., Parada L.F., and Weinberg R.A. Cellular oncogenes and multistep carcinogenesis. Science 222 4625 (1983) 771-778
37. Maxwell S.R. Prospects for the use of antioxidant therapies. Drugs 49 3 (1995) 345-361
38. Moreno F.S., Rizzi M.B.S.L., Dagli M.L.Z., and Penteado M.V.C. Inhibitory effects of β-carotene on preneoplastic lesions induced in Wistar rats by the resistant hepatocyte model. Carcinogenesis 12 10 (1991) 1817-1822
39. Murthy M.S., Rao L.N., Kuo L.Y., Toney J.H., and Marks T.J. Antitumor and toxicologic properties of the organometallic anticancer agent vanadocene dichloride. Inorganica Chimica Acta 152 (1988) 117-124
40. Ng I.O.L., Lai E.C.S., Fan S.T., Ng M., Chan A.S.Y., and So M.K.P. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 73 9 (1994) 2268-2274
41. Peraino C., Staffeldt E.F., and Ludeman V.A. Early appearance of histochemically altered hepatocyte foci and liver tumors in female rats treated with carcinogens one day after birth. Carcinogenesis 2 5 (1981) 463-465
42. Pitot H.C. Altered hepatic foci: their role in murine carcinogenesis. Annual Review of Pharmacology and Toxicology 30 (1990) 465-500
43. Pitot H.C., and Sirica A.E. The stages of initiation and promotion in hepatocarcinogenesis. Biochimica et Biophysica Acta 605 2 (1980) 191-215
44. Qin L.X., and Tang Z.Y. The prognostic molecular markers in hepatocellular carcinoma. World Journal of Gastroenterology 8 3 (2002) 385-392
45. Rotstein J., Sarma D.S., and Farber E. Sequential alterations in growth control and cell dynamics of rat hepatocytes in early precancerous steps in hepatocarcinogenesis. Cancer Research 46 5 (1986) 2377-2385
46. Rutenberg A.M., Kim H., Fischbein J.W., Hanker J.S., Wasserkrug H.L., and Selihman A.M. Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase. Journal of Histochemistry and Cytochemistry 17 (1969) 517-526
47. Sakurai H., Tamura H., and Okatani K. Mechanism for a new antitumor vanadium complex: hydroxyl radical dependent DNA cleavage by 1, 10-phenanthroline-vanadyl complex in the presence of hydrogen peroxide. Biochemical and Biophysical Research Communications 206 1 (1995) 133-137
48. Stewart H.L., Williams G.M., Keysser C.H., Lombard L.S., and Montail R.J. Histological typing of liver tumors of the rat. Journal of the National Cancer Institute 64 (1980) 117-207
49. Tatematsu M., Nagamine Y., and Farber E. Stable phenotypic expression of glutathione-S-transferase placental type and unstable phenotypic expression of γ-glutamyl transpeptidase in rat liver preneoplastic and neoplastic lesions. Carcinogenesis 9 2 (1988) 215-220
50. Wang S.S., Zhang T., Wang X.L., Hong L., and Qi Q.H. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World Journal of Gastroenterology 9 5 (2003) 930-935